Artigas, Francesc

Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data

Sanchez, C., Asin, K. E., & Artigas, F. (2015) · Pharmacology & Therapeutics

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 547

Control of Dorsal Raphe Serotonergic Neurons by the Medial Prefrontal Cortex: Involvement of Serotonin-1A, GABAA, and Glutamate Receptors

Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 497

Serotonin modulation of cortical neurons and networks

Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 462

Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research

Celada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 323

Serotonin receptors involved in antidepressant effects

Artigas, F. (2013) · Pharmacology & Therapeutics

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 311

Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex

Santana, N., Mengod, G., & Artigas, F. (2009) · Cerebral Cortex

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 231

A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder

Alvarez, E., Perez, V., Dragheim, M., Loft, H., & Artigas, F. (2012) · The International Journal of Neuropsychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 225

Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat

López-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology

Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 183

5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons

Llado-Pelfort, L., Santana, N., Ghisi, V., Artigas, F., & Celada, P. (2012) · Cerebral Cortex

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 156

A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention

Puigdemont, D., Portella, M. J., Pérez-Egea, R., Molet, J., Gironell, A., de Diego-Adeliño, J., Martín, A., Rodríguez, R., Àlvarez, E., Artigas, F., et al. (2015) · Journal of Psychiatry and Neuroscience

Deep Brain Stimulation and Movement DisordersTreatment of Major Depression

Cited by 100

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder

Alvarez, E., Artigas, F., & Perez, V. (2014) · Neuropsychiatric Disease and Treatment

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 84

Catecholamine/Serotonin Interactions

Hensler, J. G., Artigas, F., Bortolozzi, A., Daws, L. C., De Deurwaerdère, P., Milan, L., Navailles, S., & Koek, W. (2013) · Advances in Pharmacology

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 73

Preclinical and clinical characterization of the selective 5‐HT1Areceptor antagonist DU‐125530 for antidepressant treatment

Scorza, M., Lladó‐Pelfort, L., Oller, S., Cortés, R., Puigdemont, D., Portella, M., Pérez‐Egea, R., Alvarez, E., Celada, P., Pérez, V, et al. (2012) · British Journal of Pharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 46

Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson’s disease.

Bortolozzi, A., Manashirov, S., Chen, A., & Artigas, F. (2021) · Pharmacology & Therapeutics

RNA Interference and Gene DeliveryTreatment of Major Depression

Cited by 37